So, Pemigatinib is this thing that zeroes in on the fibroblast growth factor receptor (FGFR). It’s made just for cholangiocarcinoma with FGFR2 fusions, y’know? It stops that FGFR signaling thing to help with the cancer. They got it in three doses: 4.5 mg, 9 mg, and 13.5 mg tablets.
You’re supposed to take 13.5 mg a day, and you do that for 14 days out of every 21-day cycle. Every bottle comes with 14 tablets for you.
